Myriad Genetics, Inc. ( MYGN ) is currently at $4.64, down $2.63 or 36.18%
--Would be lowest close since March 17, 2003, when it closed at $4.57
--On pace for largest percent decrease since Nov. 5, 2019, when it fell 40.37%
--Currently down two consecutive days; down 39.74% over this period
--Worst two day stretch since the two days ending Aug. 15, 2019, when it fell 47.92%
--Down 37.38% month-to-date
--Down 66.16% year-to-date
--Down 92.43% from its all-time closing high of $61.27 on Nov. 6, 2000
--Down 80.63% from 52 weeks ago (May 8, 2024), when it closed at $23.95
--Down 83.78% from its 52-week closing high of $28.60 on Sept. 17, 2024
--Would be a new 52-week closing low
--Traded as low as $4.60; lowest intraday level since March 17, 2003, when it hit $4.41
--Down 36.73% at today's intraday low; largest intraday percent decrease since Nov. 5, 2019, when it fell as much as 42.74%
All data as of 11:47:18 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
May 07, 2025 11:54 ET (15:54 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.